SELLAS Life Sciences (SLS) Other Non Operating Income (2010 - 2019)
SELLAS Life Sciences' (SLS) quarterly Other Non Operating Income came in at $668000.0 in Q4 2019, down 12.79% on a QoQ basis from $766000.0 in Q3 2018.
SELLAS Life Sciences (SLS) Other Non Operating Income (2010 - 2019) Analysis & Trends
SELLAS Life Sciences (SLS) has 9 years of Other Non Operating Income data on file, last reported at $668000.0 in Q4 2019.
- On a quarterly basis, Other Non Operating Income changed N/A year-over-year to $668000.0 in Q4 2019; TTM through Dec 2019 was $1.4 million, a 87.21% increase from a year earlier, with the FY2020 full-year figure at $208000.0, down 68.86% from the prior year.
- Other Non Operating Income for Q4 2019 stood at $668000.0, down from $766000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for SLS reached as high as $766000.0 in Q3 2018 and fell as low as -$321000.0 in Q1 2015.
- Historically, Other Non Operating Income has averaged $253285.7 across 4 years, with a median of $307000.0 in 2015.
- On a YoY basis, Other Non Operating Income climbed as much as 116.9% in 2015 and fell as far as 94.55% in 2015.
- Year by year, Other Non Operating Income stood at $440000.0 in 2015, then tumbled by 138.64% to -$170000.0 in 2016, then surged by 550.59% to $766000.0 in 2018, then decreased by 12.79% to $668000.0 in 2019.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $668000.0 in Q4 2019, $766000.0 in Q3 2018, and -$170000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 668,000.00 |
| Sep 30, 2018 | 766,000.00 |
| Mar 31, 2016 | -170,000.00 |
| Dec 31, 2015 | 440,000.00 |
| Sep 30, 2015 | 307,000.00 |
| Jun 30, 2015 | 83,000.00 |
| Mar 31, 2015 | -321,000.00 |
| Dec 31, 2014 | 229,000.00 |
| Sep 30, 2014 | 597,000.00 |
| Jun 30, 2014 | -491,000.00 |
| Mar 31, 2014 | -165,000.00 |
| Dec 31, 2013 | 2.14 Mn |
| Sep 30, 2013 | 693,000.00 |
| Jun 30, 2013 | -70,000.00 |
| Mar 31, 2013 | -5.44 Mn |
| Dec 31, 2012 | 11.55 Mn |
| Sep 30, 2012 | -733,000.00 |
| Jun 30, 2012 | 5.93 Mn |
| Mar 31, 2012 | -18.27 Mn |
| Dec 31, 2011 | 7.36 Mn |